Kiromic BioPharma
upcoming milestones authorization to evaluate in non small cell lung cancer may beginning of first in human trial activation for data results from first patient in clinical trial by end of initiation of clinical trials expansion cohort submission of new for and | Kiromic BioPharma
Company
Deck Type
Sector
Industry
Deck date
May 2023
Slide
20 of 25
Related slides by other companies
Aldeyra Therapeutics
Results
October 2022
upcoming planned clinical milestones for | Aldeyra Therapeutics
argenx SE
Results
May 2023
steady cadence of upcoming data | argenx SE
NeuroSense Therapeutics
Investor Presentation
June 2023
milestones achieved upcoming potential catalysts | NeuroSense Therapeutics
argenx SE
Results
October 2023
steady cadence of upcoming data | argenx SE
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io